Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
2 drugs in development
By Therapeutic Area
top 1
R&D Momentum
62/100
Pipeline Velocity
34/100
Trial Completion Rate
69/100
Pipeline Concentration
56/100
Pipeline Freshness
0/100
Strategic Signals
Activity
Last 14 days
Implementation of a New Algorithm for HRR Gene Mutation Testing in Patients With mPC
Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion: a Randomized Phase II Biomarker Trial in Subjects at Increased Risk
ALTHEA - tAckLing menTal Health Cancer Patients and Their Families: Digital Solutions for bEtter cAre Work Package 3: Disparities in Mental Health Screening and Support
Impact of Stereotactic Radiosurgery With Cyberknife In Patients With Brain Melanoma Metastases In The Era Of New Drugs
Synchronous Bilateral Talc Pleurodesis for Malignant Bilateral Pleural Effusions
Earlier
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)